Both in Pharmaceuticals
Viking Therapeutics vs Acadia Pharmaceuticals
Over the past year VKTX returned −24.2% and ACAD returned −8.0%; their daily moves had a correlation of 0.40.
VKTX −24.2% ACAD −8.0%Growth of $1, one year, split-adjusted
| Metric | VKTX | ACAD |
|---|---|---|
| Price | $27.28 | $20.59 |
| Market cap | $3.48B | $3.55B |
| Today | +1.56% | −0.82% |
| 1 month | −10.6% | +3.5% |
| 6 months | −9.1% | −6.2% |
| Year to date | −22.5% | −22.9% |
| 1 year | −22.5% | −8.6% |
| Revenue growth (YoY) | — | +16.4% |
| Gross margin | — | 90.8% |
| Net margin | — | 10.2% |
| P/E (TTM) | — | 9.3× |
| Price / sales | — | 3.1× |
| Net cash | $709.2M | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 86.8% | 44.3% |
| Short % of float | 22.8% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).